← All stocks

ALUMIS INC.

ALMS Net buying
CIK 0001847367 #1768 in the set updated 17 Sep 2026
Bought (120 mo)
$183.99M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.55M
$0.00 on a plan · $140.00K straight out of an exercise
Sold at will
$1.41M
8 of 9 sales
Net
+$182.44M
+$182.58M against sales at will

By person

20 insiders · 69 transactions
1.6×

Martin Babler holds only 1.6 times base salary in stock. $1.13M of shares against $680.83K in salary for 2025.

Salary from the company's own proxy. The shares are what Martin Babler last reported holding, valued at $10.63, the price Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Foresite Labs, LLC entity
10% owner
$50.83M (11)
+$50.83M
680,486
$7.23M
Tananbaum James B.
Director
$50.83M (11)
+$50.83M
680,486
$7.23M
Foresite Capital Management V, LLC entity
10% owner
$40.00M (2)
+$40.00M
4,202,670
$44.66M
AKKARAJU SRINIVAS
Director
$31.27M (22)
$1.01M (2)
+$30.26M
9,092,850
$96.63M
+192.7%
Foresite Capital Management VI LLC entity
10% owner
$10.83M (9)
+$10.83M
680,486
$7.23M
+387.4%
Pangali Sanam
Chief Legal Officer
$175.97K (2) scheduled
−$175.97K
9,747
$103.58K
+777.3%
Colowick Alan
Director
$129.54K (2)
+$129.54K
18,404
$195.58K
Babler Martin
President, CEO and Chairman
$100.73K (1)
+$100.73K
106,454
$1.13M
+17.2%
Schroer John R.
Chief Financial Officer
$86.55K (1)
−$86.55K
24,718
$262.68K
Hardiman Roy C.
Chief Business & Strategy Ofcr
$70.99K (1)
−$70.99K
214,163
$2.28M
+13.4%
Goldstein David M
Chief Scientific Officer
$68.46K (1)
−$68.46K
33,964
$360.94K
+255.3%
Bradley Mark Christopher
Chief Development Officer
$67.82K (1)
−$67.82K
68,559
$728.58K
+54.5%
Drappa Jorn
Chief Medical Officer
$64.53K (1)
−$64.53K
56,892
$604.60K
+708.5%
AyurMaya Capital Management Company, LP entity
Director
15,139,707
$160.89M
Richardson Derrick
SVP, People and Culture
42,800
$454.84K
Klein Sara
Chief Legal Officer
33,796
$359.15K
0.0%
Yao Zhengbin
Director
27,082
$287.80K
+15.1%
Machado Patrick
Director
10,617
$112.83K
TETRAULT LYNN A.
Director
3,553
$37.76K
Srivastava Sapna
Director
3,553
$37.76K

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 53,752,223 to 127,690,254 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
AKKARAJU SRINIVAS
8 Sep 2026
Director
Buy indirect
273,290
$10.63
$2.90M
AKKARAJU SRINIVAS
8 Sep 2026
Director
Buy indirect
273,291
$10.63
$2.90M
AKKARAJU SRINIVAS
8 Sep 2026
Director
Sell indirect
48,065
$10.55
$507.01K
AKKARAJU SRINIVAS
8 Sep 2026
Director
Sell indirect
48,066
$10.55
$507.02K
AKKARAJU SRINIVAS
4 Sep 2026
Director
Buy indirect
220,070
$11.17
$2.46M
AKKARAJU SRINIVAS
4 Sep 2026
Director
Buy indirect
220,070
$11.17
$2.46M
Bradley Mark Christopher
3 Aug 2026
Chief Development Officer
Sell
2,572
$26.37
$67.82K
Drappa Jorn
3 Aug 2026
Chief Medical Officer
Sell
2,447
$26.37
$64.53K
Goldstein David M
3 Aug 2026
Chief Scientific Officer
Sell
2,596
$26.37
$68.46K
Hardiman Roy C.
3 Aug 2026
Chief Business & Strategy Ofcr
Sell
2,692
$26.37
$70.99K
Pangali Sanam
3 Aug 2026
Chief Legal Officer
Sell
1,364
$26.37
$35.97K
Schroer John R.
3 Aug 2026
Chief Financial Officer
Sell
3,282
$26.37
$86.55K
Pangali Sanam
6 Jul 2026
Chief Legal Officer
Sold after exercise
5,000
$28.00
$140.00K
Drappa Jorn
22 May 2026
Chief Medical Officer
Exercised, kept
15,535
$5.06
$78.61K
Drappa Jorn
22 May 2026
Chief Medical Officer
Exercised, kept
11,317
$8.84
$100.04K
AKKARAJU SRINIVAS
9 Jan 2026
Director
Buy indirect
588,235
$17.00
$10.00M
Tananbaum James B.
8 Jan 2026
Director
Buy indirect
294,117
$17.00
$5.00M
Tananbaum James B.
8 Jan 2026
Director
Buy indirect
117,647
$17.00
$2.00M
Foresite Capital Management VI LLC
8 Jan 2026
10% owner
Buy indirect
294,117
$17.00
$5.00M
Foresite Capital Management VI LLC
8 Jan 2026
10% owner
Buy indirect
117,647
$17.00
$2.00M
Foresite Labs, LLC
8 Jan 2026
10% owner
Buy indirect
294,117
$17.00
$5.00M
Foresite Labs, LLC
8 Jan 2026
10% owner
Buy indirect
117,647
$17.00
$2.00M
AKKARAJU SRINIVAS
5 Dec 2025
Director
Buy indirect
51,380
$10.73
$551.31K
AKKARAJU SRINIVAS
5 Dec 2025
Director
Buy indirect
70,028
$10.01
$700.98K
AKKARAJU SRINIVAS
5 Dec 2025
Director
Buy indirect
64,969
$8.95
$581.47K
AKKARAJU SRINIVAS
4 Dec 2025
Director
Buy indirect
66,027
$8.18
$540.10K
AKKARAJU SRINIVAS
3 Dec 2025
Director
Buy indirect
100,000
$7.75
$775.00K
AKKARAJU SRINIVAS
2 Dec 2025
Director
Buy indirect
96,000
$7.55
$724.80K
AKKARAJU SRINIVAS
1 Dec 2025
Director
Buy indirect
86,350
$7.46
$644.17K
AKKARAJU SRINIVAS
28 Nov 2025
Director
Buy indirect
38,702
$7.64
$295.68K
AKKARAJU SRINIVAS
26 Nov 2025
Director
Buy indirect
48,537
$7.64
$370.82K
Foresite Labs, LLC
21 Nov 2025
10% owner
Buy indirect
72,212
$7.38
$532.92K
Tananbaum James B.
21 Nov 2025
Director
Buy indirect
72,212
$7.38
$532.92K
Foresite Capital Management VI LLC
21 Nov 2025
10% owner
Buy indirect
72,212
$7.38
$532.92K
AKKARAJU SRINIVAS
20 Nov 2025
Director
Buy indirect
125,743
$7.20
$905.35K
AKKARAJU SRINIVAS
19 Nov 2025
Director
Buy indirect
137,772
$6.56
$903.78K
Tananbaum James B.
19 Nov 2025
Director
Buy indirect
190,500
$6.56
$1.25M
Foresite Capital Management VI LLC
19 Nov 2025
10% owner
Buy indirect
190,500
$6.56
$1.25M
Foresite Labs, LLC
19 Nov 2025
10% owner
Buy indirect
190,500
$6.56
$1.25M
AKKARAJU SRINIVAS
18 Nov 2025
Director
Buy indirect
102,652
$6.05
$621.04K
Tananbaum James B.
18 Nov 2025
Director
Buy indirect
117,374
$6.19
$726.55K
Foresite Capital Management VI LLC
18 Nov 2025
10% owner
Buy indirect
117,374
$6.19
$726.55K
Foresite Labs, LLC
18 Nov 2025
10% owner
Buy indirect
117,374
$6.19
$726.55K
AKKARAJU SRINIVAS
17 Nov 2025
Director
Buy indirect
914
$5.51
$5.04K
Tananbaum James B.
17 Nov 2025
Director
Buy indirect
150,000
$5.59
$838.50K
Tananbaum James B.
17 Nov 2025
Director
Buy indirect
50,000
$5.60
$280.00K
Foresite Capital Management VI LLC
17 Nov 2025
10% owner
Buy indirect
150,000
$5.59
$838.50K
Foresite Capital Management VI LLC
17 Nov 2025
10% owner
Buy indirect
50,000
$5.60
$280.00K
Foresite Labs, LLC
17 Nov 2025
10% owner
Buy indirect
150,000
$5.59
$838.50K
Foresite Labs, LLC
17 Nov 2025
10% owner
Buy indirect
50,000
$5.60
$280.00K
AKKARAJU SRINIVAS
13 Nov 2025
Director
Buy indirect
276,179
$5.25
$1.45M
Foresite Capital Management VI LLC
6 May 2025
10% owner
Buy indirect
20,000
$4.34
$86.80K
Foresite Labs, LLC
6 May 2025
10% owner
Buy indirect
20,000
$4.34
$86.80K
Tananbaum James B.
6 May 2025
Director
Buy indirect
20,000
$4.34
$86.80K
AKKARAJU SRINIVAS
5 May 2025
Director
Buy indirect
22,002
$5.27
$115.95K
AKKARAJU SRINIVAS
5 May 2025
Director
Buy indirect
138,368
$4.58
$633.73K
AKKARAJU SRINIVAS
2 May 2025
Director
Buy indirect
159,920
$4.55
$727.64K
Foresite Capital Management VI LLC
2 May 2025
10% owner
Buy indirect
25,000
$4.62
$115.50K
Foresite Labs, LLC
2 May 2025
10% owner
Buy indirect
25,000
$4.62
$115.50K
Tananbaum James B.
2 May 2025
Director
Buy indirect
25,000
$4.62
$115.50K
Colowick Alan
2 Apr 2025
Director
Buy indirect
2,300
$7.49
$17.24K
Babler Martin
1 Apr 2025
President, CEO and Chairman
Buy indirect
15,650
$6.44
$100.73K
Colowick Alan
1 Apr 2025
Director
Buy indirect
16,104
$6.97
$112.31K
Tananbaum James B.
1 Jul 2024
Director
Buy indirect
2,187,500
$16.00
$35.00M
Tananbaum James B.
1 Jul 2024
Director
Buy indirect
312,500
$16.00
$5.00M
Foresite Capital Management V, LLC
1 Jul 2024
10% owner
Buy indirect
2,187,500
$16.00
$35.00M
Foresite Capital Management V, LLC
1 Jul 2024
10% owner
Buy indirect
312,500
$16.00
$5.00M
Foresite Labs, LLC
1 Jul 2024
10% owner
Buy indirect
2,187,500
$16.00
$35.00M
Foresite Labs, LLC
1 Jul 2024
10% owner
Buy indirect
312,500
$16.00
$5.00M

What was left out

Form 4 filings counted 87
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 69,669,054
History held since 1 Jul 2024